Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV

Journal of Experimental Medicine

Volumn 194, Issue 12, 2001, Pages 1731-1741

  Kovacs, Joseph A ^a,d   Lempicki, Richard A ^c   Sidorov, Igor A ^b   Adelsberger, Joseph W ^c   Herpin, Betsey ^a   Metcalf, Julia A ^a   Sereti, Irini ^a   Polis, Michael A ^a   Davey, Richard T ^a   Tavel, Jorge ^a   Falloon, Judith ^a   Stevens, Randy ^c   Lambert, Laurie ^c   Dewar, Robin ^c   Schwartzentruber, Douglas J ^b   Anver, Miriam R ^c   Baseler, Michael W ^c   Masur, Henry ^a   Dimitrov, Dimiter S ^b   Clifford Lane, H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d Science Applications International Corporation ^*  (United States)

Author keywords

AIDS; Bromodeoxyuridine; CD4 T lymphocyte proliferation; CD8 T lymphocyte proliferation; Highly active antiretroviral therapy

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; BROXURIDINE; CD4 ANTIGEN; CD8 ANTIGEN; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD; CELL DEATH; CELL LABELING; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MATHEMATICAL MODEL; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; VIRUS REPLICATION;

EID: 0035905463     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.12.1731     Document Type: Article

References (31)

1. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy
2. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: A longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)
3. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
4. Viral dynamics in human immunodeficiency virus type 1 infection
5. + T cell turnover
6. + T cell turnover in HIV-infected patients
7. + T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy
8. + T lymphocytes in HIV-1 infection as measured by Ki-67 antigen
9. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
10. Factors influencing T-cell turnover in HIV-1-seropositive patients
11. Long-term telomere dynamics: Modest increase of cell turnover in HIV- infected individuals followed for up to 14 years
12. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy
13. + T-cell pool during HIV- 1 infection and triple combination therapy
14. Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: Implications for T cell proliferation in HIV disease
15. Bromodeoxyuridine: A diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization
16. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication
17. Lymphocyte life-span memory
18. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques
19. Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques
20. Bromodeoxyuridine: A diagnostic tool in biology and medicine, part II: Oncology, chemotherapy and carcinogenesis
21. Measurement of cell kinetics in cervical tumours using bromodeoxyuridine
22. The prognostic value of proliferation indices: A study with in vivo bromodeoxyuridine and Ki-67
23. Immunologic evaluation of patients with human immunodeficiency virus infection
24. Observations on human monocyte kinetics after pulse labeling
25. T cell turnover in SIV infection
26. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage
27. CD8 naive T cell counts decrease progressively in HIV-infected adults
28. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
29. Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy
30. Positivity of the proliferation marker Ki-67 in noncycling cells
31. + lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of cell cycle